Mohammed Salem

FILE PHOTO: Palestinian boy Mu'ath Mohamed Abu-Hagag, who doctors said is malnourished, cries as his mother displays a picture of him before being diagnosed as malnourished, at the ICU of

FILE PHOTO: Palestinian children suffering from malnutrition receive treatment at a healthcare center, amid widespread hunger, as the conflict between Israel and Hamas continues, in Rafah, in the southern Gaza

Palestinian mother Ghaneyma Joma sits next to her malnourished son Younis Joma as he receives treatment at Nasser hospital in Khan Younis, in the southern Gaza Strip, July 8, 2024.

Post-war moment offers rare opportunity to reshape regional ties and rebuild trust

FILE PHOTO: A Palestinian girl Jana Ayad, who is malnourished, according to medics, rests on a bed as she receives treatment at the International Medical Corps field hospital, amid the

Palestinian cameraman Hussam al-Masri, who was a contractor for Reuters and killed in Israeli strikes on Nasser hospital on August 25, 2025, stands next to his camera as he works

FILE PHOTO: Reuters journalist Hussam al-Masri, who was killed by an Israeli strike on Nasser Hospital on August 25, 2025, stands next to his camera as he works at the

The Rafah crossing will open in the next few days to let Gaza residents cross into Egypt. The arrangement, which has security clearance from Israel, will be coordinated with Egypt under the supervision of European Union representatives.

Sudan Conflict: Army's pursuit of military victory derails peace efforts, deepening humanitarian crisis. International pressure mounts for ceasefire.

Introduction: Nasal valve collapse (NVC) is a common cause of nasal obstruction that significantly impairs quality of life (QoL), which is traditionally treated via functional rhinoplasty. There is, however, no consensus on the best management for NVC. This paper describes the experience of a single district centre using the LATERA implant (Stryker, Kalamazoo, MI, USA) to treat NVC by evaluating its efficacy and safety. Complications and patient satisfaction were evaluated as secondary outcomes.Methods: A prospective study was conducted between 2022 and 2025. Eligible adults were recruited to undergo LATERA implant placement. The primary outcome of efficacy and safety of the LATERA implant was evaluated via the change in the Functional Rhinoplasty Outcome Inventory-17 (FROI-17) scores from baseline to six months post-procedure.Results: A significant improvement in FROI-17 scores was observed in 90.9% (n=20) of patients, with a mean score decrease of 38.5 points (p<0.01). No major complications, such as infection or implant extrusion, were recorded.Conclusion: The LATERA implant is a safe and effective intervention for NVC, showing a high success rate in significantly improving procedure-specific QoL in our single-centre study. These findings support its role as a valuable minimally invasive option, although further detailed comparative studies are warranted.